2-carba-cyclic phosphatidic acid
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Feb 13, 2018 (NCT04229394)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05807529 | Phase 1/Phase 2 (Phase 2) | Nov 3, 2022 | Government of Taiwan, Orient Europharma Co., Ltd. |
| NCT04229394 | Phase 1 | Feb 13, 2018 | Government of Taiwan, Orient Europharma Co., Ltd. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of Taiwan | Government | 2 | 0 | 2 | 2018 |
| Orient Europharma Co., Ltd. | For profit | 2 | 2 | 2 | 2018 |
2 organizations
Page 1 / 1